Skip to main content
HLB INC. logo

HLB INC. — Investor Relations & Filings

Ticker · 028300 ISIN · KR7028300002 LEI · 988400ZL885PLZG8E576 KO Manufacturing
Open in API
Filings indexed 555 across all filing types
Latest filing 2021-03-15 AGM Information
Country KR South Korea
Listing KO 028300

About HLB INC.

https://www.hlb.global/

HLB INC. is a biopharmaceutical company focused on developing new global anti-cancer drugs. The company's core activities center on advancing a pipeline of novel therapeutics through its worldwide network, which includes subsidiaries like Elevar Therapeutics and Immunomic Therapeutics. In addition to its primary focus on oncology, HLB's affiliated companies are involved in other life science areas, such as developing and manufacturing in vitro diagnostic medical devices, peptide-based biomaterials, and quasi-drugs. The group also has operations in composite materials and shipbuilding, reflecting its diversified origins.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for HLB Co., Ltd. It contains the meeting agenda, date, location, and detailed management information regarding board activities, remuneration, and business status. This type of document is standard for providing shareholders with the necessary information to vote at an upcoming Annual General Meeting. In the context of the provided categories, this is a Proxy Solicitation & Information Statement (PSI) as it provides the information required for shareholders to exercise their voting rights.
2021-03-15 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company cannot avoid the designated 'concentrated date' for its AGM due to audit report schedules. As this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or the results, it falls under the general regulatory filing category.
2021-03-15 Korean
권리락(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short, structured announcement regarding a 'rights off' (권리락) event due to a bonus issue (무상증자). This relates to a change in capital structure and share issuance. Among the provided categories, 'SHA' (Share Issue/Capital Change) is the most accurate classification for announcements regarding capital changes and share-related corporate actions.
2021-03-12 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the shareholding status, changes in ownership, and collateral agreements (stock-backed loans) of the major shareholder (Jin Yang-gon) and related parties of HLB Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-03-03 Korean
주요사항보고서(무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from HLB Co., Ltd. regarding a 'Decision on Bonus Issue' (무상증자결정). This filing details the issuance of new shares to existing shareholders, which constitutes a capital change. According to the provided definitions, announcements regarding new share issues or capital changes fall under the 'SHA' (Share Issue/Capital Change) category.
2021-02-26 Korean
주권매매거래정지(무상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a short regulatory notice regarding a temporary suspension of stock trading ('주권매매거래정지') for HLB due to a bonus issue ('무상증자'). It cites specific KOSDAQ market regulations and provides the duration of the suspension. Since it is a regulatory announcement regarding trading status and does not fit into specific categories like M&A or dividend announcements, it falls under the general regulatory filings category.
2021-02-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.